text:
15 Nov 2018: The PLOS ONE Staff (2018) Correction: Aerosol prime-boost vaccination provides strong protection in outbred rabbits against virulent type A Francisella tularensis. PLOS ONE 13(11): e0207721. https://doi.org/10.1371/journal.pone.0207721 View correction
Tularemia, also known as rabbit fever, is a severe zoonotic disease in humans caused by the gram-negative bacterium Francisella tularensis (Ft). While there have been a number of attempts to develop a vaccine for Ft, few candidates have advanced beyond experiments in inbred mice. We report here that a prime-boost strategy with aerosol delivery of recombinant live attenuated candidate Ft S4ΔaroD offers significant protection (83% survival) in an outbred animal model, New Zealand White rabbits, against aerosol challenge with 248 cfu (11 LD50) of virulent type A Ft SCHU S4. Surviving rabbits given two doses of the attenuated strains by aerosol did not exhibit substantial post-challenge fevers, changes in erythrocyte sedimentation rate or in complete blood counts. At a higher challenge dose (3,186 cfu; 139 LD50), protection was still good with 66% of S4ΔaroD-vaccinated rabbits surviving while 50% of S4ΔguaBA vaccinated rabbits also survived challenge. Pre-challenge plasma IgG titers against Ft SCHU S4 corresponded with survival time after challenge. Western blot analysis found that plasma antibody shifted from predominantly targeting Ft O-antigen after the prime vaccination to other antigens after the boost. These results demonstrate the superior protection conferred by a live attenuated derivative of virulent F. tularensis, particularly when given in an aerosol prime-boost regimen.
Citation: O'Malley KJ, Bowling JL, Stinson E, Cole KS, Mann BJ, Namjoshi P, et al. (2018) Aerosol prime-boost vaccination provides strong protection in outbred rabbits against virulent type A Francisella tularensis. PLoS ONE 13(10): e0205928. https://doi.org/10.1371/journal.pone.0205928
Editor: Martin Pavelka, University of Rochester, UNITED STATES
Received: August 17, 2018; Accepted: October 3, 2018; Published: October 22, 2018
Copyright: © 2018 O'Malley et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All relevant data are within the manuscript and its Supporting Information files.
Funding: DSR, EB, KH were funded by the National Institute of Allergy & Infectious Diseases at the National Institutes of Health, for the work reported in this manuscript, Grants U01 AI077909-01, R01 A102966-01A1, AI 123129, and AI 100138, niaid.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Tularemia (originally known as rabbit fever) is a severe zoonotic infection in humans caused by Francisella tularensis, a gram-negative facultative intracellular bacterium [1]. Under current taxonomical classification, there are four subspecies (subsp) of F. tularensis; subsp. tularensis (a.k.a. type A) is the most virulent, followed by subsp. holarctica (a.k.a. type B) and subsps. mediasiactica and novicida which are highly attenuated or avirulent in humans [2] (it should be noted there is some controversy whether F. novicida is a subsp of F. tularensis). Tularemia is readily treatable with antibiotics, with an overall case fatality rate less than 2%. Antibiotic resistance, either natural or engineered, is a concern; in the pre-antibiotic era fatality rates reached as high as 30–60% with the pneumonic and septicemic forms of the disease [1]. Once the organism has entered the host, it can disseminate throughout the body and infect a wide array of cell types including macrophages, dendritic cells, epithelial cells, hepatocytes and even erythrocytes. Lung, liver, spleen, and bone marrow are primary targets for bacterial replication and pathogenesis although all organs can be affected, including heart and brain [3–8]. The widespread infection is thought to induce septic shock, disseminated intravascular coagulation and/or acute respiratory distress syndrome resulting in multi-organ failure and death [1, 6].
Although not naturally spread person-to-person by respiratory transmission, F. tularensis is highly infectious when aerosolized. In the 1950s and 1960s, tularemia was one of the most common laboratory acquired infections, along with brucellosis and tuberculosis [9, 10]. Clinical trials conducted at the time determined that inhalation of a small particle aerosol (≤ 5 µm mass median aerodynamic diameter) containing as few as 15 organisms was sufficient to cause disease in humans[11]. Outbreaks of pneumonic tularemia in landscapers on Martha's Vineyard have been dubbed "lawnmower tularemia" [12, 13]. Both the former Soviet Union and the United States of America (prior to 1969) evaluated and developed F. tularensis as a biological weapon [1]. F. tularensis is considered to be a 'tier 1' select agent, pathogens considered to have the highest potential for causing severe morbidity or mortality in humans and animals in the event of an intentional release by terrorists or a rogue nation [14].
A concerted effort was made in the 1950s and 1960s to develop a vaccine for tularemia [15]. Killed, whole cell vaccines proved to be ineffective against lab-acquired tularemia. The Soviet Union developed an attenuated type B strain that was protective as a vaccine. This strain was given to the United States, where investigators passaged it further and dubbed it the "Live Vaccine Strain" (LVS). In clinical trials, LVS given by scarification gave good protection against aerosol challenge with doses ranging from 200–2,000 cfu (10–100 human infectious doses) of a virulent type A strain of Ft, SCHU S4 [11, 16]. LVS-mediated protection was not as good against higher aerosol challenge doses (20,000 cfu) but was still better than killed vaccines. Across all the parenteral LVS vaccine studies, all vaccine recipients seroconverted but not all controls developed disease, so protection is less than the desired 80%. Aerosol LVS vaccination regimens provided superior protection to intradermal inoculation in both monkeys and humans, including at high challenge doses [17–20]. LVS is currently given to at-risk laboratory personnel as an Investigational New Drug but has not been licensed, due to concerns regarding protection and safety/reversion [21]. There are ongoing efforts to re-evaluate LVS as a tularemia vaccine [22, 23] but other approaches are also being considered, including subunit vaccines, vectored vaccines, and new attempts at generating attenuated strains derived from type A.
Among the challenges in developing a tularemia vaccine is defining immune mechanisms and immune correlates that predict protection against aerosol challenge. Because F. tularensis is a facultative intracellular bacterium, cellular immune responses are thought to be of prime importance in protection. Indeed, experiments in mice have shown that T cell production of IFN-γ or control of bacterial replication in infected macrophages are associated with protection [24, 25]. A recent paper has shown that cell-mediated immune responses can also be seen in human PBMC from LVS recipients bolstering the potential for measuring cellular immune responses in a clinical trial [26]. The vast majority of licensed vaccines, however, measure antibody responses as an immune correlate of protection [27]. Studies in animals and humans have shown a role for antibody in protection against F. tularensis. Passive immunization with sera from human LVS vaccinees can protect mice against LVS challenge [28]. A study in the rat model demonstrated that passive transfer of antibody from LVS-vaccinated rats reduced the severity and duration of disease caused by intratracheal challenge with SCHU S4 [29]. In most of these antibody studies, the antibody response was directed at the lipopolysaccharide of F. tularensis, in particular against the O-antigen. While identifying the underlying mechanisms is important for understanding how a particular vaccine protects, translation to humans will be key in demonstrating comparability between results in animal models with those seen in clinical trials that will be essential for licensure under the FDA's Animal Rule [30].
With the development of systems for genetically manipulating the F. tularensis genome, attempts have been made to produce a defined attenuated vaccine strain that would not be able to revert to virulence [31–34]. Some of these vaccine candidates have shown success in inbred mouse models; few have been advanced into larger animals. We have previously reported that isogenic mutants (S4ΔaroD and S4ΔguaBA) of SCHU S4 protected rabbits against respiratory tularemia better than LVS when given as a single vaccination by scarification, although protection was not complete [35]. Based on those prior studies, we here sought to evaluate whether a prime-boost vaccination regimen utilizing S4ΔaroD or S4ΔguaBA would improve survival of rabbits after aerosol SCHU S4 challenge.
Response to prime-boost vaccination regimens
Twenty rabbits were divided into three groups of 6 rabbits with 2 rabbits used as mock-vaccinated rabbits. Mock-vaccinated rabbits were inoculated with Brain Heart Infusion broth. Rabbits were vaccinated with S4ΔaroD by scarification or aerosol and then boosted 14 days later with S4ΔaroD by the alternate route. One group received both prime and boost vaccinations by aerosol. The groups and doses achieved for each vaccination are shown in Table 1. Fig 1 shows the physiological response to the vaccination. In agreement with our prior results when rabbits were inoculated via scarification with attenuated strains of SCHU S4 [35], the first inoculation of S4ΔaroD induced a fever response regardless of route (Fig 1A). Fever (defined as body temperatures Δ 40°C) began within a day post-inoculation of rabbits with S4ΔaroD via scarification but was delayed in the aerosol S4ΔaroD-vaccinated rabbits. Regardless of route, fever persisted for 1–2 days in vaccinated rabbits and then returned to baseline temperatures. A modest increase in temperature was seen with the booster vaccination on day 14 in all three groups with no discernment between groups in the onset or duration of the response to the boost. Regardless of route of inoculation, S4ΔaroD-vaccinated rabbits lost 1–5% of their body weight between 2–4 days after the first vaccine dose (Fig 1B). By day 5 post-prime, all S4ΔaroD-vaccinated rabbits were at or above baseline. From that point forward, S4ΔaroD-vaccinated rabbits gained weight at the same rate as mock-vaccinated controls. On the day rabbits were boosted, all rabbits including the mock-vaccinated rabbits lost a slight amount of weight again but quickly rebounded.
Rabbits were vaccinated with a prime and boost of S4ΔaroD by aerosol or scarification. Mock = mock vaccinated controls, APSB = aerosol prime, scarification boost; SPAB = scarification prime, aerosol boost; APAB = aerosol prime, aerosol boost. Graphs show averaged daily group results (n = 6 per vaccine group and 2 mock-vaccinated controls); error bars are not shown for the sake of clarity. Vertical dotted lines indicate days for prime (day 0) and boost (day 14). A) Average fever response after prime (day 0) and boost (day 14) with S4ΔaroD compared to mock-vaccinated controls. The horizontal dotted line at 40°C indicates the threshold used for fever. By one-way ANOVA, temperature was significantly elevated in the SPAB group on day 1 from all other groups (p<0.0001) and on day 3 for the APAB and APSB groups from the SPAB and Mock groups (p = 0.0009 for APSB vs SPAB, p = 0.0107 for APSB vs Mock; p = 0.0073 for APAB vs SPAB, p = 0.0448 for APAB vs Mock). Fevers induced by booster vaccination were not significantly elevated over Mock-vaccinated. B) Average weight change after vaccination with S4ΔaroD. A horizontal dotted line is shown at 0% weight change to make it easier to see where weight was lost in the vaccine groups.
Survival after aerosol challenge with SCHU S4
Thirty days after the booster vaccination, rabbits were challenged by exposure to a small particle aerosol containing SCHU S4 (median inhaled dose: 248 cfu / 11 LD50; range: 77–994 cfu). Mock-vaccinated controls succumbed rapidly to the infection, within 7 days post-exposure all had become moribund and were euthanized (Fig 2A). This is within the range we have seen in the past for naïve or mock-vaccinated rabbits (4–7 days). In all three prime-boost groups, significant (p < 0.0002) protection was seen with 83% of rabbits surviving in the APAB group and 50% of rabbits surviving in both the APSB and SPAB groups when compared with mock-vaccinated and historical controls (Fig 2A). In agreement with our previous studies, mock-vaccinated controls developed a severe fever (≥41°C) post-exposure which peaked on days 4 or 5 post-exposure and then dropped before the animals succumbed to the disease (Fig 2B). Similarly, beginning on day 4 substantial weight loss (defined as ≥ 5%) was seen in the mock-vaccinated group that continued to decline until the rabbits succumbed (Fig 2C). The response to challenge in the vaccinated groups, however, was different than what we had seen previously with rabbits vaccinated once by scarification[35]. In previous vaccine studies, surviving rabbits generally developed clinical signs of disease including fever and weight loss in the post-exposure period between days 4–10 before recovering. Here, averaged daily temperatures in the prime-boost groups showed only slight fever responses (≥40°C but ≤41°C). Between days 9–13, fever was seen in the SPAB group where in the APAB and APSB groups fever was only seen on days 7 and 8. Similarly, the average daily weight loss in the prime-boost vaccine groups was less than 5% for only two time points in the SPAB group and not at all for the APAB or APSB groups. Between the three vaccine groups, the febrile response was greatest in the SPAB group and lowest in the APAB group although these differences were not significant (S1 Fig).
Rabbits were vaccinated with a prime and boost of S4ΔaroD by aerosol or scarification prior to aerosol challenge with a median dose of 248 cfu SCHU S4 (range: 77–994 cfu). Thirty days post-boost, the rabbits were challenged with SCHU S4. Survival was tracked for 28 days post-challenge; body temperature and weight were tracked until day 22, when surviving rabbits had returned to baseline values. Mock = mock vaccinated controls (n = 2); APSB = aerosol prime, scarification boost (n = 6); SPAB = scarification prime, aerosol boost (n = 6); APAB = aerosol prime, aerosol boost (n = 6). Historical naïve or mock-vaccinated controls given equivalent challenge doses are also shown (n = 9). A) Percent survival in each group after aerosol challenge with 248 cfu SCHU S4. Kaplan Meier analysis indicated survival of all three vaccine groups was significantly better than mock-vaccinated rabbits (including historical controls). APAB: 83% survival, p = 0.0002; SPAB: 50% survival, p = 0.0002; APSB: 50% survival, p = 0.0002. B) Mean fever response to aerosol challenge with SCHU S4. C) Mean weight loss after aerosol challenge with SCHU S4.
The lack of a noteworthy fever response or weight loss in the vaccine groups, particularly the aerosol primed groups, was surprising. We examined this more closely by breaking down the fever and weight loss changes to individual rabbits in the APAB group, since this group had the highest survival (Fig 3). Within that group, five rabbits survived to 28 days post-challenge while one rabbit succumbed on day 12. Of the five APAB rabbits that survived challenge, two had no fever (Fig 3A and 3E) while one had fever at only 2 points after challenge (Fig 3C). A sustained fever of more than 1 day was seen in only 2 survivors (Fig 3B and 3D). The APAB rabbit that succumbed developed a non-resolving fever on day 5 with fever peaking over 41°C (Fig 3F). Day 5 was approximately the same time that substantial weight loss (>5%) was first recorded. Similar results were seen when looking at weight loss. Only two of the five surviving APAB rabbits had weight loss >5% (from baseline) for more than 1 day post-challenge. The APAB rabbit that succumbed had steady weight loss that began with the onset of fever.
Graphs show daily temperature (solid lines) and weight (dotted lines) for six individual APAB-vaccinated rabbits after aerosol challenge (d0) with SCHU S4. A-E) Data from five APAB-vaccinated rabbits which survived challenge; F) Data from the one APAB-vaccinated rabbit which succumbed to challenge.
At set times pre- and post-challenge, blood was collected from rabbits and samples used to measure bacteremia as well as changes in complete blood count (CBC) and erythrocyte sedimentation rate (ESR) as a measure of the inflammatory response. Bacteremia levels were generally low or non-existent, even in mock-vaccinated rabbits at all time points tested (S2 Fig). In mock-vaccinated rabbits (which includes historical controls) there was a sharp rise in ESR on days 4 and 6 post-infection; these values were significantly higher than baseline (p < 0.0001) (Fig 4A). The average ESR for mock-vaccinated rabbits on day 4 was 32 mm, rising to 44 mm on day 6. In the APAB group, ESR did not rise above 10 mm at any time point post-challenge (Fig 4B). ESR levels were mildly elevated in the APSB and SPAB groups after day 4 but the average was less than 20 mm (Fig 4C and 4D). At no point post-challenge were ESR values in vaccinated rabbits significantly higher than baseline values and collectively, it suggested that ESR results predict survival. However, this is not absolute as some rabbits with high ESR survive and others with low ESR succumb. In particular, mock-vaccinated rabbits with low ESR values on day 4 still succumbed to infection.
Graphs show ESR for individual rabbits (gray triangles) with the mean (black center line) and standard deviation (error bars) on different days for rabbits that were A) mock-vaccinated, B) APAB vaccinated with S4ΔaroD, C) APSB vaccinated with S4ΔaroD, or D) SPAB with S4ΔaroD. Mock-vaccinated includes historical controls, shown as open squares. Bars with *** indicate where differences were statistically significantly different from baseline as measured by one-way ANOVA, p < 0.0001.
CBC results showed a decrease in WBC at day 4 in the mock-vaccinated rabbits and in the APAB rabbits (S3 Fig). This drop in WBC was entirely due to a loss of lymphocytes, with no substantive change in granulocytes and macrophages (S4–S6 Figs). In contrast, elevations in granulocytes were seen in rabbits from all three vaccine groups (S5 Fig). Platelet counts remained largely unchanged in vaccinated rabbits while in mock-vaccinated rabbits there was a decrease in platelet counts on day 4 below the level considered indicative of thrombosis in humans (150x103/µl) (S7 Fig). ESR and CBC results are consistent across all vaccine groups and with the lack of a febrile response suggest minimal or no inflammatory response to challenge in vaccinated prime-boost survivors. In keeping with that, gross pathology of lungs and spleens from rabbits found considerable pathology in mock-vaccinated or vaccinated rabbits that succumbed to challenge but no obvious pathology in lungs or spleens from prime-boost vaccinated survivors (S8 Fig).
Protection against higher lethal aerosol challenge doses
We sought to repeat these promising results for APAB S4ΔaroD vaccination against a higher challenge dose as well as evaluate whether a similar improvement in protection could be seen with S4ΔguaBA using an APAB regimen, another vaccine that had shown promising results when given once by scarification. In addition, because the initial prime-boost vaccination study used a lower challenge dose (~10 LD50) we included a third APAB vaccine group given S4ΔaroD to evaluate protection against an even higher challenge dose (~300 LD50). Eighteen rabbits were split into three groups of six; one group received S4ΔguaBA while the other two groups received S4ΔaroD. Vaccination doses are shown in Table 2. For each challenge dose we included 2 control, mock-vaccinated rabbits. As we had seen before, vaccination was well tolerated by the rabbits with minimal, transient fever and weight loss after delivery of either the prime or boost (S9 Fig). Thirty days after the second vaccination, the S4ΔguaBA & S4ΔaroD rabbits (and associated controls) were aerosol challenged with SCHU S4 at a median dose of 1,475 cfu (64 LD50) and the higher challenge dose S4ΔaroD group and associated controls received 6,316 cfu (275 LD50). As expected from prior studies, mock-vaccinated rabbits at both challenge doses succumbed within 4–5 days of infection. In the 'low' challenge dose groups, 66% that received S4ΔaroD survived challenge while 50% that received S4ΔguaBA survived challenge. At the higher challenge dose, 66% that received S4ΔaroD survived infection. Similar to what we had observed with the first prime-boost study, rabbits in the vaccine groups at either challenge dose had less fever and weight loss post-challenge compared to the mock-vaccinated rabbits (Fig 5B and 5C).
Rabbits were vaccinated by APAB with S4ΔaroD or S4ΔguaBA prior to aerosol challenge with SCHU S4. Graphs show survival among rabbits vaccinated with S4ΔaroD and S4ΔguaBA and challenged with 1,475 cfu (solid and dotted lines, respectively) as well as S4ΔaroD vaccinated rabbits challenged with 6,316 cfu (designated aroD (high), dashed line). Survival was tracked for 28 days post-challenge; body temperature and weight were tracked until day 18–21, when rabbits had returned to baseline values. Mock-vaccinated rabbits are also shown. Graphs show A) survival post-challenge. By Kaplan-Meier analysis, survival in all three vaccine groups was significantly different from mock vaccinated controls. S4ΔguaBA: 50% survival, p = 0.0018; S4ΔaroD: 66% survival, p = 0.0018; S4ΔaroD(high challenge dose): 66% survival, p = 0.0018. Historical naïve or mock-vaccinated controls given equivalent challenge doses are also shown (n = 29). B) average body temperature by group post-challenge, and C) average weight loss by group post-challenge.
Vaccination induces strong plasma IgG responses to SCHU S4
Having established that live attenuated S4-based vaccines could provide safe, effective protection against S4 in the rabbit model, we sought to determine whether the immune response could predict protection. We previously demonstrated that antibody responses against heat-killed SCHU S4 might be useful for predicting protection [36]. Regardless of the prime-boost regimen used, plasma IgG titers 28 days after vaccination (2 days prior to challenge) with S4ΔaroD were significantly higher than mock-vaccinated rabbits (p < 0.0001)(Fig 6A). Rabbits given a scarification prime and aerosol boost (SPAB) had higher plasma IgG titers than rabbits that received an aerosol prime, scarification boost (APSB) or both doses by aerosol (APAB), and these differences were statistically significant (p = 0.0006 and p = 0.0067 for APSB and APAB, respectively). Antibody titers to prime-boost vaccination (regardless of route) were also significantly higher than antibody responses to a scarification prime only (S10 Fig). We next compared plasma IgG titers between rabbits that received an APAB with either S4ΔaroD or S4ΔguaBA (Fig 6B). Plasma IgG titers in both groups were significantly higher than mock-vaccinated rabbits (p < 0.0001) but were not significantly different from one another (p = 0.7413). We also looked at earlier time points for plasma IgG titers induced by APAB S4ΔaroD. At all timepoints post-vaccination, plasma IgG titers were highly significantly different from pre-vaccination IgG titers (p < 0.0001)(Fig 6C). Post-vaccination, plasma IgG titers peaked at day 7 post-vaccination and gradually declined out to day 28. Differences between plasma IgG titers on day 7 post-vaccination were significantly different from day 21 and 28 post-vaccination (p = 0.0216 and p < 0.0001 for d21 and d28, respectively). We then compared whether plasma IgG titers taken 2 days pre-challenge across all vaccine studies (including re-analyzed plasma from prior studies with a single vaccination only [35, 36]) could predict survival from challenge. Plasma IgG responses to SCHU S4 did correspond with longer survival after challenge; one-way ANOVA was able to determine a significant linear trend (p = <0.0001, r2 = 0.5183)(Fig 6D). It should be noted, however, that beyond day 6 survival the trend does flatten somewhat. Plasma IgA responses did not correspond with survival (S11 Fig).
Rabbits were bled post-vaccination and the plasma antibody response was assessed by ELISA. Values shown are the median effective concentration (EC50) values for plasma IgG responses against heat-killed SCHU S4 in rabbits. Statistical tests were done by one-way ANOVA. A) day 28 post-vaccination plasma IgG responses to rabbits vaccinated with S4ΔaroD by aerosol prime, aerosol boost (APAB), scarification prime, aerosol boost (SPAB) or aerosol prime, scarification boost (APSB)(n = 6/group). Results from mock-vaccinated rabbits. ** indicates a statistically significant difference by ANOVA, p = 0.0067; *** indicates a significant difference, p = 0.0006; **** = highly significant differences, p<0.0001. B) Graph shows comparison between plasma IgG titers on day 28 post-vaccination for rabbits vaccinated by APAB with S4ΔaroD (n = 12) or S4guaBA (n = 6). Mock-vaccinated rabbits are shown for comparison; **** = highly significant differences, p <0.0001. C) change in plasma IgG titers over time for S4ΔaroD; days shown are post-vaccination; * = significant difference, p = 0.0215; **** = highly significant differences, p <0.0001.One-way ANOVA analysis was used to determine significant differences between pre- and post-vaccination bleeds; * = significant, p <0.05, **** = highly significant, p<0.0001. D) Graph shows day 28 post-vaccination (day -2 relative to challenge) IgG titer (y-axis) compared to survival time (in days) after aerosol challenge with SCHU S4 (x-axis) across all vaccine groups from all studies conducted to date including mock-vaccinated rabbits (n = 107 rabbits, including studies reported here and [35, 36]). ANOVA analysis indicated a linear trend in which higher plasma IgG responses to SCHU S4 predicted longer survival time in days (p = 0.0001, r2 = 0.5183).
Western blot analysis using lysates of wild type (WT) and O-antigen-deficient (wbtA) Ft LVS revealed that the plasma IgG response to a single vaccination (prime-only) with either S4ΔaroD or S4ΔguaBA is largely directed at the bacterium's O-antigen and a small subset of proteins most readily observed in an O-Ag Ft mutant, wbtA (Fig 7). Note that detection of the bacterium's O-Ag (the repeating carbohydrate moiety found in variable numbers on the bacterium's heterogeneous LPS) yields a typical "ladder pattern" visible in WT, but not wbtA, an O-Ag-deficient, Ft. Following a boost, the antibody repertoire broadens to include a greater number of O-Ag-independent antigens (presumed to be proteins) with some modest divergence between the S4ΔaroD- and S4ΔguaBA-induced Ab responses (compare reactivity of the prime-boost S4ΔguaBA and S4ΔaroD plasma with the wbtA strain in the ~35 and ~22 kDa range). Identification of these putative, differentially-recognized bands and a more-accurate quantitative and qualitative analysis of these Ab responses is ongoing. The results of our antibody ELISA and western blot analyses suggest that antibody responses to specific Ft antigens may be of value as a potential correlate of protection. We are continuing to investigate this question.
Whole cell lysates of Ft LVS wildtype (WT) and the O-Antigen deficient LVS mutant (wbtA) grown in BHI broth were loaded into 9 wells of an SDS-PAGE gel prior to resolution and transfer to a nitrocellulose membrane. The membrane was reversibly stained with amido black and cut into 5 sections with 2 lanes/section. The sections were probed in parallel with the indicated 5 rabbit sera pools prior to simultaneous chemiluminescent development. Western blot immuno-reactivity with the bacterium's LPS (which is decorated to varying degrees with O-Ag) resolved by SDS-PAGE typically reveals a characteristic LPS ladder pattern in WT Ft (left lanes for each vaccine) but not in Ft deficient for O-Ag such as wbtA (right lanes for each vaccine)[56–58]. * notes bands at ~35 and ~22 kDal that are different between the antibody response to S4ΔaroD and S4ΔguaBA.
We have previously shown that a single vaccination by scarification with deletion mutants of SCHU S4 outperformed LVS in the outbred rabbit model of lethal aerosol SCHU S4 challenge[35]. In those initial studies, LVS only extended time to death while some rabbits vaccinated with the recombinant mutants (S4ΔaroD and S4ΔguaBA) survived aerosol challenge with SCHU S4 (27 & 36%, respectively). We subsequently demonstrated that the protection elicited by LVS vaccination could be improved by delivering the vaccine by either oral gavage or small-particle aerosols [36]. As the next step, we decided to evaluate whether a prime-boost regimen would further improve vaccine-mediated protection in rabbits. We present data here demonstrating that prime-boost regimens of a deletion mutant of SCHU S4 delivered by aerosol and/or scarification provides significant protection in outbred NZW rabbits against aerosol challenge with SCHU S4. This included a reduction in morbidity as well as survival from challenge. The data further suggests that the combination of aerosol prime and aerosol boost provided the best protection, although these differences were not significant in the experiments reported here. We further demonstrated that the pre-challenge plasma IgG response in vaccinated rabbits corresponded with survival, suggesting antibody could be a useful correlate of protection. Given the level of attenuation and the high level of protection seen against robust challenge doses, S4ΔaroD warrants further evaluation as a promising tularemia vaccine candidate.
There is a question whether challenge dose is determining the outcomes we see. Certainly, in the initial experiment reported here we saw higher overall survival with the lower challenge dose (median: 248 cfu; 11 LD50) compared to prior studies. However, mock-vaccinated rabbits did not survive challenge and the time to death for mock-vaccinated rabbits was not significantly different from prior studies with higher challenge doses (S1 Table). In the second vaccine study we used higher challenge doses in order to determine whether the protection afforded by prime-boost vaccination would be similar against a more rigorous challenge. There is some variation between individual animals in terms of the vaccination doses and challenge doses; this variation is the result of differences in respiratory function between rabbits that causes them to inhale different volumes of air during aerosols, which were a fixed 10-minute duration. However, there are no significant differences in doses between groups within individual experiments and we have found no correlation between challenge dose and survival of vaccinated rabbits whether comparing individual rabbits or groups of rabbits (by one way ANOVA, p = 0.3818, r2 = 0.1195, S1 Table). In fact, in the initial experiment reported here the APAB group had the highest overall median challenge dose (455 cfu) yet had the best overall survival in that experiment.
While it was expected that a prime-boost vaccination regimen would improve protection, we did not expect that delivering both doses by aerosol would be better than the combinations of scarification and aerosol (although this difference did not rise to the level of significance). We thought that scarification would provide stronger systemic immunity while aerosol delivery would provide stronger immune responses at the site of entry. Aerosol-primed rabbits, regardless of the route of boost, had less morbidity than the scarification primed-group. Rabbits primed with S4ΔaroD by scarification did have higher plasma α-hkSCHU S4 IgG titers on day 28 than rabbits that were primed by aerosol, although this did not improve survival. Based on that and our prior ELISA results against LVS endotoxin, it was surprising then that across all the vaccine studies we have done in rabbits, pre-challenge plasma α-hkSCHU S4 IgG titer on day 28 post-vaccination did roughly correspond with protection post-challenge. Rabbits with low plasma IgG titers (<2.5 log10 EC50) to whole, heat-killed SCHU S4 did not survive long. Survival time was extended at higher titers, although titers >3log10 EC50 did not insure survival. IgA titers in plasma did not correspond with survival at all, but it is possible that we would have seen different results had we looked at IgA in mucosal secretions. Data from the literature support a role for both cellular or antibody immune responses in vaccine-mediated protection against F. tularensis. In some studies, antibody titers have been shown to predict protection and passive immunization has provided at least limited protection in animal studies [28, 37–44]. Other studies have presented contrary findings [11, 44, 45]. Considering that F. tularensis is a facultative intracellular bacterium yet can have a significant extracellular phase, it seems likely that antibody and cellular immune responses would have complementary roles in a protective response. The results we present here suggest plasma IgG titer may serve as a correlate of protection against tularemia. That does not mean that antibody is the mechanism by which S4ΔaroD (or S4ΔguaBA) immunized rabbits are protected against SCHU S4.
A more refined approach, looking at specific antigens rather than a crude, killed preparation of bacteria should provide a better answer on the role of antibody. Western blots of plasma IgG response from S4ΔaroD and S4ΔguaBA-vaccinated rabbits suggested that the prime vaccination generated antibody mostly against O-antigen while the boost vaccination resulted in stronger antibody responses against protein antigens. The identity of these protein antigens and their relationship with rabbit survival is an active area of investigation. Analyses of the immunoproteome to F. tularensis have been reported by others in mice and humans [39], however to our knowledge this is the first report in a large outbred animal with a challenge component where pre-challenge antibody responses from vaccinated survivors and non-survivors are compared. Considering the overall strength of the antibody response to vaccination in the rabbits, a refined ELISA focusing on specific F. tularensis antigens, not whole, heat-killed bacteria, may prove to be a better correlate. This is an area we are actively exploring, as well as evaluating antibody in mucosal tissues, antibody subtypes, and functional antibody responses.
Another striking finding was the overall low or non-existent fever and ESR response after challenge in the surviving prime-boost vaccinated rabbits. In our prior study with single vaccinations, all rabbits challenged with SCHU S4 including survivors developed a fever by no later than day 4 post-challenge [35]. In prior studies with naive rabbits, we had seen that lymphopenia and thrombocytopenia, coupled with a rise in ESR, are associated with fatal disease and that this is similar to what has been reported in humans [4]. We saw similar results in the mock-vaccinated rabbits in these studies but not in the prime-boost vaccinated rabbits, a surprising contrast from the prior single vaccination studies. This suggests that the aerosol prime-boost regimen generated very strong, protective immunity with little or no morbidity in a susceptible outbred animal model.
In summary, we have demonstrated here that priming and boosting by aerosol delivery of an attenuated recombinant derivate of SCHU S4 offers strong protection against a virulent Ft aerosol challenge. The level of protection was nearly complete, even at high challenge doses. We would envision pursuing a similar strategy in humans, similar to respiratory delivery of vaccines for influenza or measles [46–49]. Aerosol delivery would build on the time-honored premise of the oral Sabin vaccine, that vaccination at the site of pathogen entry is superior to parenteral inoculation in the protection conferred. Future efforts will build on the results detailed here, particularly to determine the immunological mechanisms and antigens important for this protection.
Materials & methods
Biosafety and regulatory information
All work with live F. tularensis was conducted at biosafety level (BSL)-3 in the University of Pittsburgh Regional Biocontainment Laboratory (RBL). For respiratory protection, all personnel wore powered air purifying respirators (3M GVP-1 PAPR with L-series bumpcap) or used a class III biological safety cabinet. Vesphene II SE (1:128 dilution, Steris Corporation, Erie, PA) was used to disinfect all liquid wastes and surfaces associated with the agent. All solid wastes, used caging, and animal wastes, were steam-sterilized. Animal carcasses were digested via alkaline hydrolysis (Peerless Waste Solutions, Holland, MI). The University of Pittsburgh Regional Biocontainment Laboratory is a Registered Entity with the CDC/USDA for work with F. tularensis. The University of Pittsburgh's Biohazard Committee approved these studies. Work with recombinant Francisella tularensis strains was approved by the University of Pittsburgh's Institutional Biosafety Committee.
Animal studies
All animal work performed for this publication adhered to the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health (NIH) and the Animal Welfare Act (AWA). All studies were performed under protocols approved by the University of Pittsburgh's Institutional Animal Care and Use Committee (Protocols: 1105929 & 14053602). The University of Pittsburgh is fully accredited by the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC). Rabbits were monitored at least once daily prior to infection and at least twice daily after infection. For blood collection, rabbits were anesthetized with 2–5% isoflurane and bled from the saphenous vein. Rabbits that were determined to be moribund (any of the following clinical signs: weight loss ≥ 20%, body temperature < 34°C, unresponsive to prodding, respiratory distress) were first anesthetized with isoflurane (2–5%) and then euthanized promptly by barbiturate overdose (100 mg/kg sodium pentobarbital given i.v. or i.c.). Five of the forty-two rabbits (12%) in these studies did succumb prior to administration of euthanasia; this was within the 20% anticipated in the approved protocols.
Young female New Zealand White (NZW) rabbits (Robinson Services, Inc.) were housed in the University of Pittsburgh Regional Biocontainment Laboratory (RBL) at ABSL-3 for the duration of the studies. Prior to vaccination, IPTT-300 temperature/ID chips (BioMedic Data Systems, Seaford, DE) were implanted subcutaneously. Body weight was recorded once in the morning and body temperature was recorded twice daily. Temperature was read using a DAS-7000 reader (BioMedic Data Systems).
F. tularensis SCHU S4 was originally obtained from the Dynport Vaccine Company respectively and were stored as single-passage stocks [4]. F. tularensis SCHU S4 ΔaroD and SCHU S4 ΔguaBA, generated as previously described in the laboratories of Dr. Eileen Barry and Dr. Barbara Mann, were shipped to the University of Pittsburgh for these experiments[31, 50–52]. F. tularensis was grown first on Cysteine Heart Agar (CHA) for two days prior to growing overnight in Brain Heart Infusion (BHI) broth supplemented with ferric pyrophosphate and L-cysteine[53, 54] using baffled, vented polycarbonate Erlenmeyer flasks [4]. Attenuated strains were grown in 200 ml cultures using 1 L flasks, concentrated by centrifuging at 4,000x g for 10 minutes and resuspended in fresh BHI broth for aerosolization.
Vaccination by scarification
Rabbits were vaccinated by scarification or by aerosol exposure. For scarification, rabbits were anesthetized by subcutaneous injection of ketamine (80 mg/kg) and xylazine (8 mg/kg); once anesthesia was confirmed a small area of the dorsal surface was shaved. Approximately 0.1 ml of bacteria at a concentration of 1x1010 cfu/ml were placed in a drop on the shaved area and a bifurcated needle (Becton Dickinson) was jabbed through the drop of bacteria into the skin 17 times. The drop was allowed to absorb into the skin, after which the xylazine was reversed by i.m. injection of 0.2–1 mg/kg yohimibine. The scarification site was monitored daily for the first seven days after vaccination.
Aerosol exposures (vaccinations and challenge)
Aerosols of F. tularensis were generated inside a class III biological safety cabinet (Baker Co., Sanford, ME) located inside the RBL as previously described [4]. Briefly, rabbits were exposed two at a time for 10 minutes in a nose-only exposure chamber (CH Technologies, Westwood, NJ) using a 3-jet Collison nebulizer while plethysmography data was collected using Buxco XA or Finepointe software (Buxco Research Systems, Wilmington, NC) during the exposure. After the exposures were completed, nebulizer and all-glass impinger (AGI) contents were quantified on CHA. Aerosol concentration and inhaled (presented) dose were determined as described previously [55]. Mock-vaccinated rabbits were exposed to aerosols of Brain Heart Infusion broth.
ELISA were performed using standard ELISA procedures. Briefly, dilutions of rabbit sera were incubated for 1 hour at 37°C on 96-well plates coated with heat-killed F. tularensis SCHU S4. Duplicate wells were used for each dilution. A positive control was included on every plate using plasma drawn on day 28 from a vaccinated rabbit that survived SCHU S4 challenge. After washing with PBS-Tween, secondary goat anti-rabbit IgG-HRP (Fitzgerald Industries, Acton, MA) was added to the plates and incubated for 1 hour at 37°C, after which the plates were washed again with PBS-Tween and BM Chemiluminescence ELISA Substrate (Roche Applied Sciences, Indianapolis, IN) was added to the plates. Plates were then read on an Lmax plate reader (Molecular Devices, Sunnyvale, CA). Median effective concentration (EC50) was determined by four-parameter logistical regression of ELISA data using GraphPad Prism 6.
Erythrocyte sedimentation rates (ESR)
rabbit whole blood collected in EDTA was pipetted using a glass Pasteur pipet into glass Wintrobe tubes. After one hour, the degree of sedimentation was recorded in mm for each rabbit.
rabbit whole blood collected in EDTA was analyzed on a VetScan HM2 (Abaxis, Union City, CA) to determine the white blood cell counts including granulocytes, macrophages, and lymphocytes as well as platelets.
SDS-PAGE and western blot analysis
Whole cell samples containing 10 μg of Ft protein (~1x108 cells) were mixed with Laemmli sample buffer and boiled for 10 min prior to resolution through 4–12% gradient SDS-PAGE pre-cast gels (NuPAGE Bis-Tris, Invitrogen). The running buffer was NuPAGE MES SDS buffer from Invitrogen; gels were run at 120 V. Resolved gels were stained with either Coomassie blue (BioRad) or transferred to nitrocellulose membranes. Coomassie-stained gels were scanned into Adobe Photoshop using an HP LaserJet Pro 300 color (MFP-m375nw) scanner. Membranes were cut into sections, each containing one lane of WT and one lane of wbtA. Membrane sections were blocked in parallel for 30 min with PBS, 0.05% Tween 20, 5% non-fat dry milk. Rabbit sera (α-PBS, α-S4ΔguaBA prime, α- S4ΔaroD prime, α- S4ΔguaBA prime-boost, α- S4ΔaroD prime-boost) were applied in parallel for overnight incubation at a dilution of 1:1000 in PBS, 0.05% Tween 20. HRP-conjugated goat anti-rabbit secondary Ab (Southern Biotech 4010–05) was used at a dilution of 1:5000 in PBS, 0.05% Tween 20. Development of the chemiluminescent substrate (SuperSignal West Pico, Pierce, Rockford, IL) from the 5 individual membrane sections was visualized simultaneously using an BioRad ChemiDoc Touch Imaging System.
Supporting information
S1 Fig. Febrile response to challenge.
Graph shows the % of time points post-challenge that were scored as febrile (body temperature ≥ 40oC) for individual rabbits in the different vaccine groups. Individual rabbits that survived challenge are marked with gray triangles while rabbits that succumbed are marked with a gray X. Means and standard deviations are indicated by black bars for each group.
S2 Fig. Bacteremia after challenge.
Graphs show bacteremia levels (in cfu/ml of blood) for individual rabbits (gray triangles) with the mean (black center line) and standard deviation (error bars) on different days for rabbits that were A) mock-vaccinated, B) APAB vaccinated with S4ΔaroD, C) APSB vaccinated with S4ΔaroD, D) SPAB vaccinated with S4ΔaroD.
S3 Fig. Changes in White Blood Cell (WBC) count after challenge in different vaccine groups.
Graphs show WBC for individual rabbits (gray triangles) with the mean (black center line) and standard deviation (error bars) on different days for rabbits that were A) mock-vaccinated, B) APAB vaccinated with S4ΔaroD, C) APSB vaccinated with S4ΔaroD, D) SPAB vaccinated with S4ΔaroD. Mock-vaccinated includes historical controls, shown as open squares.
S4 Fig. Changes in lymphocyte (LYM) count after challenge in different vaccine groups.
Graphs show LYM for individual rabbits (gray triangles) with the mean (black center line) and standard deviation (error bars) on different days for rabbits that were A) mock-vaccinated, B) APAB vaccinated with S4ΔaroD, C) APSB vaccinated with S4ΔaroD, D) SPAB vaccinated with S4ΔaroD. Mock-vaccinated includes historical controls, shown as open squares.
S5 Fig. Changes in granulocyte (GRA) count after challenge in different vaccine groups.
Graphs show GRA for individual rabbits (gray triangles) with the mean (black center line) and standard deviation (error bars) on different days for rabbits that were A) mock-vaccinated, B) APAB vaccinated with S4ΔaroD, C) APSB vaccinated with S4ΔaroD, D) SPAB vaccinated with S4ΔaroD. Mock-vaccinated includes historical controls, shown as open squares.
S6 Fig. Changes in monocyte (MON) count after challenge in different vaccine groups.
Graphs show MON for individual rabbits (gray triangles) with the mean (black center line) and standard deviation (error bars) on different days for rabbits that were A) mock-vaccinated, B) APAB vaccinated with S4DaroD, C) APSB vaccinated with S4DaroD, D) SPAB vaccinated with S4DaroD. Mock-vaccinated includes historical controls, shown as open squares.
S7 Fig. Changes in platelet (PLT) count after challenge in different vaccine groups.
Graphs show PLT for individual rabbits (gray triangles) with the mean (black center line) and standard deviation (error bars) on different days for rabbits that were A) mock-vaccinated, B) APAB vaccinated with S4DaroD, C) APSB vaccinated with S4DaroD, D) SPAB vaccinated with S4DaroD. Mock-vaccinated includes historical controls, shown as open squares.
S8 Fig. Gross pathological changes after challenge.
Figure shows gross pathology in lungs (A, C, E, G) and spleen (B, D, F, H) of rabbits at time of necropsy. Representative examples are shown. (A,B) mock vaccinated rabbit that succumbed to challenge; (C, D) APAB vaccinated rabbit that succumbed to challenge; (E, F) APAB vaccinated rabbit that survived challenge; (G, H) S4aroD scarification prime only vaccinated rabbit that survived challenge.
S9 Fig. Fever and weight loss after aerosol prime/boost vaccination with S4ΔaroD or S4ΔguaBA.
Rabbits were vaccinated with a prime and boost of S4ΔaroD or S4ΔguaBA by aerosol. Two groups of rabbits received S4ΔaroD in order to evaluate protection against higher challenge doses. Graphs show averaged daily group results (n = 6 per vaccine group and 4 mock-vaccinated controls); error bars indicate standard deviation. Vertical dotted lines indicate days for prime (day 0) and boost (day 14). A) Average fever response after prime (day 0) and boost (day 14) with S4ΔaroD and S4ΔguaBA compared to mock-vaccinated controls. The horizontal dotted line at 40°C indicates the threshold used for fever. B) Average weight change after vaccination with S4ΔaroD or S4ΔguaBA. A horizontal dotted line is shown at 0% weight change to make it easier to see where weight was lost in the vaccine groups.
S10 Fig. Day 28 plasma IgG responses to prime only and prime-boost regimens.
Figure shows day 28 post-vaccination plasma IgG response to rabbits that received S4DaroD via either scarification prime only (SP) or the different prime-boost regimens; APSB (aerosol prime, scarification boost), SPAB (scarification prime, aerosol boost), APAB (aerosol prime, aerosol boost) or mock-vaccinated rabbits. One-way ANOVA was performed to determine significance; * p < 0.05, *** p < 0.05, Δ 0.0001). Includes re-analyzed samples from Stinson et al (2016) and Reed et al (2014).
S11 Fig. Day 28 plasma IgA responses.
Figure shows day 28 plasma IgG titer (y axis) in relation to survival after challenge (x axis). One-way ANOVA found no correlation between IgA titer and survival after challenge (p = 0.4926, r2 = 0.2611).
S1 Table. Relationship between dose and outcome.
We thank the Division of Laboratory Animal Resource's veterinary technicians who work in the University of Pittsburgh's Regional Biocontainment Laboratory and assisted with these studies. We would also like to thank Nicolas Garcia and Le'Kneitah Smith, former technicians in the Reed lab who were instrumental in starting our rabbit tularemia efforts.
- 1. Dennis DT, Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, et al. Tularemia as a biological weapon: medical and public health management. JAMA. 2001;285(21):2763–73. Epub 2001/06/21. doi: jst10001 [pii]. pmid:11386933.
- 2. McLendon MK, Apicella MA, Allen LA. Francisella tularensis: taxonomy, genetics, and Immunopathogenesis of a potential agent of biowarfare. Annual review of microbiology. 2006;60:167–85. Epub 2006/05/18. pmid:16704343; PubMed Central PMCID: PMC1945232.
- 3. Glynn AR, Alves DA, Frick O, Erwin-Cohen R, Porter A, Norris S, et al. Comparison of experimental respiratory tularemia in three nonhuman primate species. Comparative immunology, microbiology and infectious diseases. 2015;39:13–24. Epub 2015/03/15. pmid:25766142; PubMed Central PMCID: PMC4397973.
- 4. Reed DS, Smith L, Dunsmore T, Trichel A, Ortiz LA, Cole KS, et al. Pneumonic tularemia in rabbits resembles the human disease as illustrated by radiographic and hematological changes after infection. PLoS One. 2011;6(9):e24654. Epub 2011/09/21. pmid:21931798; PubMed Central PMCID: PMC3172242.
- 5. Pullen RL, Stuart B.M. Tularemia: analysis of 225 cases. Journal of the American Medical Association. 1945;129:495–500.
- 6. Hutt JA, Lovchik JA, Dekonenko A, Hahn AC, Wu TH. The Natural History of Pneumonic Tularemia in Female Fischer 344 Rats after Inhalational Exposure to Aerosolized Francisella tularensis Subspecies tularensis Strain SCHU S4. Am J Pathol. 2017;187(2):252–67. pmid:27939130; PubMed Central PMCID: PMCPMC5389373.
- 7. Makara MA, Hoang KV, Ganesan LP, Crouser ED, Gunn JS, Turner J, et al. Cardiac Electrical and Structural Changes During Bacterial Infection: An Instructive Model to Study Cardiac Dysfunction in Sepsis. J Am Heart Assoc. 2016;5(9). pmid:27620887; PubMed Central PMCID: PMCPMC5079037.
- 8. van de Beek D, Steckelberg JM, Marshall WF, Kijpittayarit S, Wijdicks EF. Tularemia with brain abscesses. Neurology. 2007;68(7):531. pmid:17296921.
- 9. Pike RM, Sulkin SE, Schulze ML. Continuing Importance of Laboratory-Acquired Infections. Am J Public Health Nations Health. 1965;55:190–9. pmid:14269202; PubMed Central PMCID: PMCPMC1256177.
- 10. Sulkin SE, Pike RM. Survey of laboratory-acquired infections. Am J Public Health Nations Health. 1951;41(7):769–81. Epub 1951/07/01. pmid:14846999.
- 11. Saslaw S, Eigelsbach HT, Prior JA, Wilson HE, Carhart S. Tularemia vaccine study. II. Respiratory challenge. Arch Intern Med. 1961;107:702–14. Epub 1961/05/01. pmid:13746667.
- 12. Feldman KA, Enscore RE, Lathrop SL, Matyas BT, McGuill M, Schriefer ME, et al. An outbreak of primary pneumonic tularemia on Martha's Vineyard. N Engl J Med. 2001;345(22):1601–6. Epub 2002/01/05. pmid:11757506.
- 13. Teutsch SM, Martone WJ, Brink EW, Potter ME, Eliot G, Hoxsie R, et al. Pneumonic tularemia on Martha's Vineyard. N Engl J Med. 1979;301(15):826–8. Epub 1979/10/11. pmid:481515.
- 14.
http://www.selectagents.gov/Select%20Agents%20and%20Toxins%20List.html: HHS & USDA; 2011 [cited 2011 August 23]. National Select Agent Registry].
- 15. Burke DS. Immunization against tularemia: analysis of the effectiveness of live Francisella tularensis vaccine in prevention of laboratory-acquired tularemia. J Infect Dis. 1977;135(1):55–60. Epub 1977/01/01. pmid:833449.
- 16. McCrumb FR. Aerosol Infection of Man with Pasteurella Tularensis. Bacteriol Rev. 1961;25(3):262–7. Epub 1961/09/01. pmid:16350172.
- 17. Tulis JJ, Eigelsbach HT, Hornick RB. Oral vaccination against tularemia in the monkeys. Proc Soc Exp Biol Med. 1969;132(3):893–7. Epub 1969/12/01. pmid:4982863.
- 18. Hornick RB, Eigelsbach HT. Aerogenic immunization of man with live Tularemia vaccine. Bacteriol Rev. 1966;30(3):532–8. Epub 1966/09/01. pmid:5917334.
- 19. Hornick RB, Dawkins AT, Eigelsbach HT, Tulis JJ. Oral tularemia vaccine in man. Antimicrob Agents Chemother (Bethesda). 1966;6:11–4. Epub 1966/01/01. pmid:4860768.
- 20. Eigelsbach HT, Tulis JJ, McGavran MH, White JD. LIVE TULAREMIA VACCINE I.: Host-Parasite Relationship in Monkeys Vaccinated Intracutaneously or Aerogenically. J Bacteriol. 1962;84(5):1020–7. Epub 1962/11/01. pmid:16561967.
- 21. Marohn ME, Barry EM. Live attenuated tularemia vaccines: Recent developments and future goals. Vaccine. 2013. Epub 2013/06/15. pmid:23764535.
- 22. Pasetti MF, Cuberos L, Horn TL, Shearer JD, Matthews SJ, House RV, et al. An improved Francisella tularensis live vaccine strain (LVS) is well tolerated and highly immunogenic when administered to rabbits in escalating doses using various immunization routes. Vaccine. 2008;26(14):1773–85. Epub 2008/03/01. doi: S0264-410X(08)00037-6 [pii] pmid:18308432.
- 23. El Sahly HM, Atmar RL, Patel SM, Wells JM, Cate T, Ho M, et al. Safety, reactogenicity and immunogenicity of Francisella tularensis live vaccine strain in humans. Vaccine. 2009;27(36):4905–11. Epub 2009/07/02. pmid:19567246; PubMed Central PMCID: PMC2726995.
- 24. De Pascalis R, Mittereder L, Kennett NJ, Elkins KL. Activities of Murine Peripheral Blood Lymphocytes Provide Immune Correlates That Predict Francisella tularensis Vaccine Efficacy. Infect Immun. 2016;84(4):1054–61. pmid:26810039; PubMed Central PMCID: PMCPMC4807470.
- 25. De Pascalis R, Chou AY, Ryden P, Kennett NJ, Sjostedt A, Elkins KL. Models derived from in vitro analyses of spleen, liver, and lung leukocyte functions predict vaccine efficacy against the Francisella tularensis Live Vaccine Strain (LVS). mBio. 2014;5(2):e00936. Epub 2014/04/10. pmid:24713322; PubMed Central PMCID: PMC3993856.
- 26. Eneslatt K, Golovliov I, Ryden P, Sjostedt A. Vaccine-mediated mechanisms controlling replication of Francisella tularensis in human peripheral blood mononuclear cells using a co-culture system. Frontiers in cellular and infection microbiology. 2018;8:1–11. pmid:29404279
- 27. Amanna IJ, Slifka MK. Contributions of humoral and cellular immunity to vaccine-induced protection in humans. Virology. 2011;411(2):206–15. pmid:21216425; PubMed Central PMCID: PMCPMC3238379.
- 28. Drabick JJ, Narayanan RB, Williams JC, Leduc JW, Nacy CA. Passive protection of mice against lethal Francisella tularensis (live tularemia vaccine strain) infection by the sera of human recipients of the live tularemia vaccine. Am J Med Sci. 1994;308(2):83–7. Epub 1994/08/01. pmid:8042659.
- 29. Mara-Koosham G, Hutt JA, Lyons CR, Wu TH. Antibodies contribute to effective vaccination against respiratory infection by type A Francisella tularensis strains. Infect Immun. 2011;79(4):1770–8. Epub 2011/02/02. pmid:21282410; PubMed Central PMCID: PMC3067570.
- 30.
FDA. Guidance for Industry: Animal Models—Essential Elements to Address Efficacy Under the Animal Rule: FDA; 2014. Guidance for Industry: Animal Models—Essential Elements to Address Efficacy Under the Animal Rule]. Available from: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM399217.pdf.
- 31. Santiago AE, Mann BJ, Qin A, Cunningham AL, Cole LE, Grassel C, et al. Characterization of Francisella tularensis Schu S4 defined mutants as live-attenuated vaccine candidates. Pathogens and disease. 2015;73(6):ftv036. Epub 2015/05/20. pmid:25986219; PubMed Central PMCID: PMC4462183.
- 32. Ryden P, Twine S, Shen H, Harris G, Chen W, Sjostedt A, et al. Correlates of protection following vaccination of mice with gene deletion mutants of Francisella tularensis subspecies tularensis strain, SCHU S4 that elicit varying degrees of immunity to systemic and respiratory challenge with wild-type bacteria. Mol Immunol. 2013;54(1):58–67. Epub 2012/12/04. pmid:23201853.
- 33. Chu P, Cunningham AL, Yu JJ, Nguyen JQ, Barker JR, Lyons CR, et al. Live attenuated Francisella novicida vaccine protects against Francisella tularensis pulmonary challenge in rats and non-human primates. PLoS Pathog. 2014;10(10):e1004439. Epub 2014/10/24. pmid:25340543; PubMed Central PMCID: PMC4207810.
- 34. Jones BD, Faron M, Rasmussen JA, Fletcher JR. Uncovering the components of the Francisella tularensis virulence stealth strategy. Frontiers in cellular and infection microbiology. 2014;4:32. pmid:24639953; PubMed Central PMCID: PMCPMC3945745.
- 35. Reed DS, Smith LP, Cole KS, Santiago AE, Mann BJ, Barry EM. Live Attenuated Mutants of Francisella tularensis Protect Rabbits against Aerosol Challenge with a Virulent Type A Strain. Infect Immun. 2014;82(5):2098–105. Epub 2014/03/13. pmid:24614653.
- 36. Stinson E, Smith LP, Cole KS, Barry EM, Reed DS. Respiratory and oral vaccination improves protection conferred by the live vaccine strain against pneumonic tularemia in the rabbit model. Pathog Dis. 2016;74(7). pmid:27511964.
- 37. Kirimanjeswara GS, Olmos S, Bakshi CS, Metzger DW. Humoral and cell-mediated immunity to the intracellular pathogen Francisella tularensis. Immunol Rev. 2008;225:244–55. Epub 2008/10/08. pmid:18837786.
- 38. Kirimanjeswara GS, Golden JM, Bakshi CS, Metzger DW. Prophylactic and therapeutic use of antibodies for protection against respiratory infection with Francisella tularensis. J Immunol. 2007;179(1):532–9. pmid:17579074
- 39. Kilmury SL, Twine SM. The francisella tularensis proteome and its recognition by antibodies. Frontiers in microbiology. 2010;1:143. Epub 2010/01/01. pmid:21687770; PubMed Central PMCID: PMC3109489.
- 40. Stenmark S, Lindgren H, Tarnvik A, Sjostedt A. Specific antibodies contribute to the host protection against strains of Francisella tularensis subspecies holarctica. Microb Pathog. 2003;35(2):73–80. pmid:12901846.
- 41. Lu Z, Perkins HM, Sharon J. Antibodies to both terminal and internal B-cell epitopes of Francisella tularensis O-polysaccharide produced by patients with tularemia. Clin Vaccine Immunol. 2014;21(2):227–33. pmid:24351753; PubMed Central PMCID: PMCPMC3910946.
- 42. Lu Z, Madico G, Roche MI, Wang Q, Hui JH, Perkins HM, et al. Protective B-cell epitopes of Francisella tularensis O-polysaccharide in a mouse model of respiratory tularaemia. Immunology. 2012;136(3):352–60. pmid:22486311; PubMed Central PMCID: PMCPMC3385035.
- 43. Roche MI, Lu Z, Hui JH, Sharon J. Characterization of monoclonal antibodies to terminal and internal O-antigen epitopes of Francisella tularensis lipopolysaccharide. Hybridoma (Larchmt). 2011;30(1):19–28. Epub 2011/04/07. pmid:21466282; PubMed Central PMCID: PMC3119334.
- 44. Skyberg JA. Immunotherapy for tularemia. Virulence. 2013;4(8):859–70. pmid:23959031; PubMed Central PMCID: PMCPMC3925717.
- 45. Elkins KL, Bosio CM, Rhinehart-Jones TR. Importance of B cells, but not specific antibodies, in primary and secondary protective immunity to the intracellular bacterium Francisella tularensis live vaccine strain. Infect Immun. 1999;67(11):6002–7. Epub 1999/10/26. pmid:10531260; PubMed Central PMCID: PMC96986.
- 46. de Swart RL, de Vries RD, Rennick LJ, van Amerongen G, McQuaid S, Verburgh RJ, et al. Needle-free delivery of measles virus vaccine to the lower respiratory tract of non-human primates elicits optimal immunity and protection. NPJ Vaccines. 2017;2:22. pmid:29263877; PubMed Central PMCID: PMCPMC5627256.
- 47. Liashenko VA, Krasnova VP, Youminova NV. Measles IgA in the nasal washings of adult volunteers and children immunized intranasally with measles vaccine L-16 [In Process Citation]. Hum Antibodies. 1999;9(3):143–8. pmid:10690626
- 48. Fernandez-de Castro J, Kumate-Rodriguez J, Sepulveda J, Ramirez-Isunza JM, Valdespino-Gomez JL. [Measles vaccination by the aerosol method in Mexico]. Salud Publica Mex. 1997;39(1):53–60. pmid:9092098
- 49. Jackson LA, Holmes SJ, Mendelman PM, Huggins L, Cho I, Rhorer J. Safety of a trivalent live attenuated intranasal influenza vaccine, FluMist, administered in addition to parenteral trivalent inactivated influenza vaccine to seniors with chronic medical conditions. Vaccine. 1999;17(15–16):1905–9. pmid:10217588
- 50.
Barry EM, Santiago, A.E., Mann, B.J., editor A highly protective type A-based live attenuated F. tularensis vaccine. Seventh International Conference on Tularemia; 2012; Breckenridge, CO.
- 51. Santiago AE, Cole LE, Franco A, Vogel SN, Levine MM, Barry EM. Characterization of rationally attenuated Francisella tularensis vaccine strains that harbor deletions in the guaA and guaB genes. Vaccine. 2009;27(18):2426–36. Epub 2009/04/17. pmid:19368784; PubMed Central PMCID: PMC2716139.
- 52. Qin A, Scott DW, Thompson JA, Mann BJ. Identification of an essential Francisella tularensis subsp. tularensis virulence factor. Infect Immun. 2009;77(1):152–61. Epub 2008/11/05. pmid:18981253; PubMed Central PMCID: PMC2612291.
- 53. Faith SA, Smith LP, Swatland AS, Reed DS. Growth conditions and environmental factors impact aerosolization but not virulence of Francisella tularensis infection in mice. Frontiers in cellular and infection microbiology. 2012;2:126. Epub 2012/10/23. pmid:23087911; PubMed Central PMCID: PMC3468843.
- 54. Holland KM, Rosa SJ, Kristjansdottir K, Wolfgeher D, Franz BJ, Zarrella TM, et al. Differential Growth of Francisella tularensis, Which Alters Expression of Virulence Factors, Dominant Antigens, and Surface-Carbohydrate Synthases, Governs the Apparent Virulence of Ft SchuS4 to Immunized Animals. Frontiers in microbiology. 2017;8:1158. pmid:28690600; PubMed Central PMCID: PMCPMC5479911.
- 55.
Roy CJ, Pitt L.M. Infectious Disease Aerobiology: Aerosol Challenge Methods. In: Swearengen JR, editor. Biodefense: Research Methodology and Animal Models. Boca Raton, FL: CRC Press; 2005. p. 61–76.
- 56. Zarrella TM, Singh A, Bitsaktsis C, Rahman T, Sahay B, Feustel PJ, et al. Host-adaptation of Francisella tularensis alters the bacterium's surface-carbohydrates to hinder effectors of innate and adaptive immunity. PLoS One. 2011;6(7):e22335. Epub 2011/07/30. pmid:21799828; PubMed Central PMCID: PMC3142145.
- 57. Gunn JS, Ernst RK. The structure and function of Francisella lipopolysaccharide. Ann N Y Acad Sci. 2007;1105:202–18. Epub 2007/03/31. pmid:17395723; PubMed Central PMCID: PMC2742961.
- 58. Okan NA, Chalabaev S, Kim TH, Fink A, Ross RA, Kasper DL. Kdo hydrolase is required for Francisella tularensis virulence and evasion of TLR2-mediated innate immunity. mBio. 2013;4(1):e00638–12. pmid:23404403; PubMed Central PMCID: PMCPMC3573668.


text:
Residential tenancy agreement vic pdf - Fairer Safer Housing Engage Victoria
saurashtra ni rasdhar part 2 pdf
Jhaverchand Meghani has 48 books on Goodreads with 4039 ratings. Jhaverchand Meghani's most popular book is Sorathi Baharvatiya.
cambridge english pronouncing dictionary pdf
Cambridge English Pronouncing Dictionary Great ebook you want to read is Cambridge English Pronouncing Dictionary. We are sure you will love the Cambridge English Pronouncing Dictionary.
automotive repair industry marcoms and campaign pdf
Related federal programs. EPA's Automotive Refinishing Safety Information EPA's Design for the Environment's (DfE) best practices project (1997-2013) was a voluntary partnership with the collision repair industry and schools to promote safer alternatives and best practices to reduce risk in the workplace and community.
bhaja govindam meaning in telugu pdf
BHAJA GOVINDAM Tranlation With Telugu Script - Download as Word Doc (.doc), PDF File (.pdf), Text File (.txt) or read online. O Scribd é o maior site social de leitura e publicação do mundo. Buscar Buscar
the sniper short story questions pdf
Quiz on all the Short Stories. Take this quiz! During the novel, "The Sniper", in what war did the conflict occur? In what city did "The Sniper", take place in? The Primary Combatints in this war were the Repulicans and Free Staters. Was the sniper a rebulican or free stater? What did the Sniper eat on the rooftop? In total, how many people does the sniper kill during this short story. Where
formal and informal socialisation pdf
Mode of Socialisation: Comparing Effects of Informal and Formal Socialisation on Organisational Performance: 10.4018/978-1-59904-549-8.ch016: The book starts with an introduction to theoretical foundations of knowledge management concepts, proceeds with a …
You can find us here:
Australian Capital Territory: Penrith ACT, Queanbeyan ACT, Wallaroo ACT, Duntroon ACT, Flynn ACT, ACT Australia 2627
New South Wales: Maldon NSW, Ernestina NSW, Wattamolla NSW, Budderoo NSW, Clunes NSW, NSW Australia 2033
Northern Territory: Muirhead NT, Eaton NT, Moil NT, Holmes NT, Coolalinga NT, Tiwi NT, NT Australia 0814
Queensland: Herberton QLD, Moonford QLD, East Deep Creek QLD, Dundowran QLD, QLD Australia 4079
South Australia: Erskine SA, Marble Hill SA, Croydon SA, Meadows SA, Mallala SA, Quinyambie SA, SA Australia 5029
Tasmania: Glenorchy TAS, Mt Nelson TAS, Hadspen TAS, TAS Australia 7058
Victoria: Shepherds Flat VIC, Aberfeldy VIC, Bridge Creek VIC, Diamond Creek VIC, Tyrendarra VIC, VIC Australia 3001
Western Australia: Geraldton WA, Yoongarillup WA, Moulyinning WA, WA Australia 6013
British Columbia: Nelson BC, Revelstoke BC, Delta BC, View Royal BC, Port McNeill BC, BC Canada, V8W 6W4
Yukon: Teslin River YT, Kynocks YT, Ballarat Creek YT, Faro YT, Braeburn YT, YT Canada, Y1A 2C3
Alberta: Longview AB, Airdrie AB, Mundare AB, Ponoka AB, Red Deer AB, St. Albert AB, AB Canada, T5K 5J1
Northwest Territories: Enterprise NT, Whati NT, Fort McPherson NT, Nahanni Butte NT, NT Canada, X1A 6L2
Saskatchewan: Kenaston SK, Sheho SK, Mervin SK, Duval SK, Ridgedale SK, Midale SK, SK Canada, S4P 4C9
Manitoba: Hamiota MB, Elkhorn MB, Neepawa MB, MB Canada, R3B 5P2
Quebec: Amqui QC, Saint-Joseph-de-Beauce QC, Beaupre QC, Delson QC, Fossambault-sur-le-Lac QC, QC Canada, H2Y 9W4
New Brunswick: Salisbury NB, Saint-Leolin NB, Beaubassin East NB, NB Canada, E3B 3H3
Nova Scotia: Glace Bay NS, Mulgrave NS, North Sydney NS, NS Canada, B3J 6S9
Prince Edward Island: O'Leary PE, Lower Montague PE, Charlottetown PE, PE Canada, C1A 7N6
Newfoundland and Labrador: Point May NL, Port Saunders NL, Millertown NL, Point Lance NL, NL Canada, A1B 8J9
Ontario: Aughrim ON, Dongola ON, Elm Tree ON, Biscotasing, Waverley ON, Ballycroy ON, Harkaway ON, ON Canada, M7A 3L8
Nunavut: Cape Dorset NU, Pond Inlet NU, NU Canada, X0A 8H9
England: Cannock ENG, Wolverhampton ENG, Carlton ENG, Beeston ENG, Littlehampton ENG, ENG United Kingdom W1U 9A7
Northern Ireland: Belfast NIR, Craigavon (incl. Lurgan, Portadown) NIR, Belfast NIR, Belfast NIR, Craigavon (incl. Lurgan, Portadown) NIR, NIR United Kingdom BT2 5H1
Scotland: Kirkcaldy SCO, East Kilbride SCO, Livingston SCO, Paisley SCO, Kirkcaldy SCO, SCO United Kingdom EH10 6B4
Wales: Swansea WAL, Neath WAL, Newport WAL, Wrexham WAL, Wrexham WAL, WAL United Kingdom CF24 9D4

subset: commoncrawl


text:
Terre Haute Girls
Hookup Girls has become one of the fastest-growing dating networks where you can meet hot girls in Terre Haute without any charge, registration is simple and only takes a minute.
Find hot girls from Indiana Women including Terre Haute and nearby cities,
West Terre Haute (1 miles), North Terre Haute (5 miles), Seelyville (8 miles), Clinton (13 miles), Fairview Park (14 miles), Farmersburg (15 miles), Marshall (15 miles), Brazil (15 miles), Paris (18 miles), Shelburn (19 miles), Rockville (22 miles), Montezuma (22 miles), Jasonville (23 miles), Sullivan (25 miles), Martinsville (26 miles), Chrisman (27 miles), Greencastle (31 miles), Linton (32 miles), Worthington (33 miles), Casey (32 miles), Cayuga (33 miles), Cloverdale (33 miles), Palestine (33 miles), Robinson (36 miles), Georgetown (37 miles), Spencer (36 miles), Bloomfield (39 miles), Charleston (40 miles).
Find women in Terre Haute or browse Indiana Women for more cities. Registration is completely free and anonymous.
75 N 3rd St
Terre Haute
United States
Indiana Women
Charleston Girls
There are approximately 227 registered profiles from Terre Haute. Including surrounding areas of West Terre Haute, North Terre Haute, Seelyville, Clinton, Fairview Park, Farmersburg, Marshall, Brazil, Paris, Shelburn, Rockville, Montezuma, Jasonville, Sullivan, Martinsville, Chrisman, Greencastle, Linton, Worthington, Casey, Cayuga, Cloverdale, Palestine, Robinson, Georgetown, Spencer, Bloomfield, Charleston, there are over 605 members and growing every day.


text:
people too see !
hello again! i hope you are well!
i go back to school tomorrow wich i am both sad and excited about. the holidays have been great! doing nothing and not having to feel guilty about it is something i rather enjoy! i have not left auckland these holidays but i have been daydreaming of all the places i would like to venture to when i have finished school.
i thought i would share some of them …
enjoy! xxx
santorini + i have always admired greece, all those blues and whites. santorini looks so calming and relaxing.
melbourne + i have been to australia before and i love it! i have a friend that lives in melbourne so i hope to travel here sooner rather than later!
hawaii + everything that i love is in hawaii! surf beaches, pineapples, snorkelling …
amsterdam + this is my top place to go! not quite sure why but the culture and buildings really make me get oh so excited!
bye bye!


text:
Hi, I downloaded a cryengine launcher from website but it's not complated because thare is file names "warlaunch.cab" is missing or corrapt how to fix it?
Where did you download the CRYENGINE Launcher from?
Please download it from here: https://www.cryengine.com/download
as the version you have downloaded does seems to be outdated.
Answer by DeathTollZzZ · Aug 01, 2018 at 06:41 AM
This is not really an answer, but I got the same problem too. As you can see here.
Answer by cry-jose · Aug 01, 2018 at 12:16 PM
@DeathTollZzZ @metrograms , please download the latest CRYENGINE Launcher from our website https://www.cryengine.com and try again, if you have futher issue, please contact us on the forums https://forum.cryengine.com/viewforum.php?f=54&sid=16abfd25c1c3bdc12c6795e4e6d9bfb3
4 People are following this question.
Сryengine does not run gives error ... when you start writing ,the Sandbox program does not work 7 Answers
Failed to launch the project editor 1 Answer
Can you please provide a link to download this project? 2 Answers
i want to use cryengine 3 but idont have its account what should i do 1 Answer
How to create your own engine version for launcher? 1 Answer


text:
I know that some princess diana's rs turbo escort of the brothel colombia new girls here at London escorts who are new to kinky sex, are a little bit inexperienced when it comes to hiding marks.
2 3, narrow your search to the type of escort that you want.I dont like people touching my neck and throat, but my friend Amanda who works for another London escorts service loves.Whenever you are in the city, you are always looking for ways of knowing the main attractions.Her regulars at London escorts know what she is like, but some of her other dates, dont really marriage and prostitution in the rover seem to appreciate those red paddle marks.If she does not answer yes to both of those questions then you are breaking the law.It is therefore only fair that you obtain the services of the most beautiful and cultured escorts the city has to offer.How about injuries to the neck and throat?Fine, no problem, we will offer you that.I have created this website with ONE reason.I had never thought about doing that, but some of the fake tattoos you can buy, especially the good quality ones, do look really good.Warnings Check the age of the escort beforehand.Oh, and do not worry about your own privacy, because we are a discreet bunch.To ensure that you get what you want, we have assembled a diverse team of cheap London escorts from all around.By using our site, you agree to our cookie policy.4, do not attempt to negotiate the price with an escort.Do not attempt to exchange sex for money.
The idea on how to revenge myself on my ex popped into my head at a party thrown by our London escorts service.This money is only for her time(not for any illegal services).We are not blind to the dictates of your pocket, which is why we have a very fair pricing strategy.Only take your cell phone, cash and keys with you.If you do find you get burns from ropes, it is a good idea to have the right kind of bling to cover it up with.They know that ropes can cause a lot of injuries which can take time to heal.


text:
Isabella. I ready dating
Pro account
i will visit you in any area within the m25 or zones 1 to 6 and will also travel further for longer bookings.. Search sex contacts.
My name is Nika, I'm hot and sexy always fresh and great sense of humor. I like verry mutch the massage. It is intristing touch somebody, I love kontakt with another person. I want thet when you leave my masege you leave very happy, my masage will be not only relax but excitement and satisfaction. I want pamper you, how long you want. I will be tender. I want to fill every your wish.. My work keeps me very busy and my 8 year old means everything to me.. I have to say that this story is exactly like Okayama is…. I like to fuck in the back with three hot men.
Sexy moms seeking usa online dating Horny local girls search looking girls for sex
Sexual Fantasies:
✅Pole Dancing
✅Anal Play
✅Rimming (receiving)
✅Massage erotic
✅Hand Relief
✅Travel Companion
Note: You must be logged in to post a review.


text:
- 3 beds
- 4 baths
- $884,000 price
- 3462425 mls id
- Square Feet: 3,359 sqft
- Year Built: 2016
Exquisite European village inspired, luxury living in desirable Easton Park. The exterior features beautiful tumbled brick, decorative coach lights, a covered terrace on front & back, cobblestone stamped concrete driveway, 2 car garage, & a rear enclosed courtyard with brick pavers, planting areas, & irrigation system. The interior is breathtaking with elegant moldings throughout, 10' ceilings on first floor, & seamless hardwood flooring. The chef's kitchen has Thermador Professional series stainless steel appliances, an extensive kitchen island, & Eudy's custom cabinetry. The heart of the home is the 2 story living room with gas fireplace that overlooks the private courtyard that is larger than most in the community & covered terrace. The master suite on main boast designer touches & has heated floors in the en-suite with recirculating hot water. Easton Park is a unique intimate community with walking trails, reserve area, & natural pond. Energy star certified.
- Site Link
- Style European
Related Listings
36 Pictures
BEST EASTERN VIEW OF CHARLOTTE SKYLINE (with exception to the penthouse)! Awesome location in ever growing South End - be in the heart of it all - step out the door onto 4.5 miles of Rail Trail, new restaurants everywhere, nightlife, ride the Light Rail to work or walk just a few blocks to Uptown...
315 Arlington Avenue Charlotte, NC
3 beds, 2 baths, 2,212 sqft, $798,500
30 Pictures
Featured on the '16 Plaza Midwood Home Tour, 1812 Truman Road is filled with character and designed for entertaining. Wide open living/dining/breakfast/kitchen on floor one, with a welcoming front porch and back dining porch. Spacious kitchen has a wet bar with wine fridge, custom painted grey...
1812 Truman Road Charlotte, NC
3 beds, 3 baths, 3,703 sqft, $799,000
27 Pictures
Welcome to The Towers at Mattie Rose, a dutch village inspiration with the modern conveniences of urban living. Admire all the fine details that went into making such a beautiful neighborhood nestled into historic Elizabeth. Once a trolley car neighborhood, Elizabeth is bustling with wonderful...
3 beds, 3 baths, 2,677 sqft, $799,900
35 Pictures
Let the summer lake fun begin in this main channel waterfront home offering lots of privacy and no HOA! Enjoy the rustic charm with lots of stone and wood trim work throughout. Multiple decks and covered areas to take in the amazing views of Lake Wylie's main channel. Large sandy beach area for the...
15155 Annalong Road Charlotte, NC
3 beds, 5 baths, 5,526 sqft, $799,999
29 Pictures
Historic charm, modern updates, and premier Eastover location, walking distance to popular boutiques, restaurants, and parks! This stunning 3 bedroom, 2.5 bath home features high ceilings, hardwood floors throughout, crown moldings, designer light fixtures, open floor plan, formal dining and living...
2127 Crescent Avenue Charlotte, NC
3 beds, 2 baths, 2,459 sqft, $800,000
22 Pictures
1938 is one of the four distinctive homes in the Scott Avenue Townhomes community. Located in historic Dilworth and less than a block from East Blvd the home is walkable to dozens of shops, restaurants, banks, grocery stores and more. Close to Latta and Freedom Parks with easy access to the...
1938 Scott Avenue Charlotte, NC
3 beds, 2 baths, 2,826 sqft, $820,000
Courtesy of: Wilkinson ERA Real Estate
Office Phone: +18286938471
Listing Agent: Gina Creson
Updated: 25th April, 2019 10:24 PM.
5917 Tred Avon Ct Charlotte, NC


text:
VIRUS ALERT NOTIFICATION - April 21, 2011
A new computer scam that extorts money through long-distance telephone charges is being targeted at Windows users.
Like RogueWare Security Applications, these infections will most likely get downloaded via infected websites.
The mistakenly downloaded infection (Trojan Virus) installs on their system, and displays the following message on their Windows PC:
"This copy of Windows is locked. You may be a victim of fraud or there may be an internal error."
In order to regain control of their PC, victims are instructed to "reactivate" their copy of Windows online or via Telephone. However, the infection is designed to purposely fail whenever the online option is chosen leaving the user with only one option – the telephone. Users are then given one of six numbers to dial (promising that the call is free of charge and that they will receive a special code to "reactivate" their software.)
Instead, the scammers who pretend to be Microsoft representatives forward the call to an automated call center which keeps the user on hold for several minutes, whereby racking up heavy long-distance charges.
The long-distance charges are how the scammers make their money, by billing at a call rate that is higher than reasonable.
This type of infection is known as "Ransom-Ware", where the malware tries to extort a payment in exchange for returning control of the PC or files to the user. Although this practice has been a round for a while, new ways to perpetuate the scam appear all the time.
Make sure your PCs are up to date with the latest Windows patches, and that your Antivirus software is up to date.


text:
Lecture series – u.s. science support program electricity experiments elementary school
Plants – from lush rainforests to desert shrublands – map climatic differences on the landscape. The waxy molecules coating plant leaves are some of the most resilient biochemicals made by plants and they contribute to the sedimentary legacy of past environment, archived in deep sea sediments. The International Ocean Discovery Program has recently drilled the two largest submarine fans in the world, the Bengal Fan (Expedition 354) and Indus Fan (Expedition 355). These megafans yield thick deposits of dominantly terrestrial organic matter derived from the Ganges-Brahmaputra and Indus River systems respectively. In addition, legacy cores from the Gulf of Aden (Expedition 24) contain wind-blown terrestrial organic material from NE Africa. From each of these expeditions we have uncovered a record of landscape change and I weave these together with terrestrial evidence into an integrated story of landscape and climate change around the shores of the Indian Ocean. Plant waxes are key to this story as their C isotopic composition reflects photosynthetic pathway and their H isotopic composition that of precipitation. Dual analyses in the same plant wax molecules allow climate and ecology to be tracked in tandem. Using this approach, we find unequivocal evidence that drying in the core monsoon region coincided with the widespread development of C4 grasslands. These plant wax records provide dramatic illustration of the sensitivity of ecosystems to climatic change in one of the most flood and drought prone, and highly populous, regions of the globe.
Dr. gas hydrates wiki Feakins is an Associate Professor of Earth Sciences at the University of Southern California. She received her Ph.D. from Columbia University and was a NOAA Postdoctoral Fellow at Caltech. Sarah has worked on deep sea drilling cores for the past 15 years. A graduate student and a postdoctoral researcher from her group sailed as shipboard scientists on two consecutive IODP Expeditions (Expeditions 354 and 355).
Monsoonal regions in Asia are natural laboratories for studying the interplay between tectonics, climate and the biosphere. At human time scales, monsoon rains are critical to the well-being of billions of people. Scientific drilling has been crucial in uncovering the history of the monsoon. Dr. Giosan will review past milestones in monsoon research: from the potential role of Himalaya-Tibet uplift on establishing the monsoon and proposed feedbacks with mountain building via erosion to the effect of monsoon rain variability on ancient civilizations. The review will address long-running dilemmas and conflicting interpretations such as the potential decoupling of monsoon winds from monsoon rains and the role of Cenozoic global cooling in modulating the monsoon vs. the role of monsoon erosion and weathering in establishing the late Cenozoic "Icehouse."
Recently the International Ocean Discovery Program drilled in the Indian and Pacific Oceans and objectives of multiple expeditions were designed to solve monsoon quandaries. Using past and novel multiproxy reconstructions, Dr. electricity vs magnetism Giosan will present the concept of a monsoon erosional pump modulated by topography and land cover to reconcile conflicting interpretations, reassess the history of the monsoon, and estimate potential effects on elemental cycles during the Cenozoic. Under this new framework, the monsoon exhibits two distinct flavors that can be largely explained by its heartbeat, or astronomical forcing, mediated by the global glacial state and the paleogeography of South Asia. Finally, Dr. Giosan will discuss how this new understanding of the monsoon helps us explore the past civilizations of Asia with their periods of flourishing or collapse and the lessons that these hold for us in the Anthropocene.
Dr. Giosan is a tenured Associate Scientist at the Woods Hole Oceanographic Institution on Cape Cod, Massachusetts. He has spent more than a year at sea on national and international research expeditions, including four ODP/IODP expeditions, and has been involved in a number of onshore field programs in Romania, Bulgaria, Spain, Pakistan, India, Myanmar, Botswana, Alaska and Arctic Canada.
IODP drilling of marine sediments around southern Africa during Expedition 361 offers exciting opportunities to elucidate the long-term role of the Agulhas Current System in ocean circulation and southern African climate variability through the past 5 (as much as 7) million years. The Agulhas Current is the strongest western boundary current in the Southern Hemisphere, transporting some 70 Sv of warm, saline surface water from the tropical Indian Ocean along the East African margin to the tip of Africa. electricity in salt water experiment Exchanges of heat and moisture with the atmosphere influence southern African climates, including individual weather systems such as extratropical cyclone formation in the region and rainfall patterns. Recent ocean model and paleoceanographic data suggest that the Agulhas Current may be a factor in the strength and mode of the Atlantic Meridional Overturning Circulation (AMOC) during the Late Pleistocene. Expedition 361 obtained records that will allow documenting paleoclimate and paleoceanography of this region. The main objectives of the expedition were to establish the sensitivity of the Agulhas Current to climatic changes during the Pliocene–Pleistocene, to determine the dynamics of the Indian-Atlantic gateway circulation during this time, to examine the connection of the Agulhas leakage and AMOC, and to address the influence of the Agulhas Current on African terrestrial climates and coincidences with human evolution.
Fine-grained sediments such as mudstones are the most common sedimentary rocks preserved close to Earth's surface. Mudstones are very susceptible to developing significant amounts of overpressure because their low permeability and high compressibility prevent pore fluids from draining. This can result in seepage, submarine landslides, or damage to offshore infrastructure. Additionally, mudrocks are fundamentally important as source, seal, and shale gas/oil reservoirs in petroleum systems or as seals for anthropogenic-related storage. In spite of the importance of mudstones to significant hazards and industry endeavors, a systematic, process-based understanding of the controls on hydromechanical properties in mudstones remains elusive. To study these questions Dr. Reece fabricates mudstones in her laboratory from natural, marine sediments, acquired through the International Ocean Discovery Program and its predecessors, using a technique called resedimentation. Resedimentation simulates the natural process of deposition and shallow burial under controlled conditions, is repeatable, and eliminates the problem of coring disturbance associated with testing on intact cores. Therefore, resedimentation is an ideal method for the study of fundamental mechanical behavior of marine sediments. In combination with microscale imaging techniques it also reveals how porosity, permeability, and fabric evolve with burial. Dr. Reece particularly focuses on the interactions between fine-grained detrital particles, microorganisms, microfossils, and pore fluid and their roles in early diagenesis. Here, Dr. Reece will present results from investigations of early chemical and physical diagenesis using mudstones from the Gulf of Mexico (IODP Expedition 308) and offshore Japan (IODP Expedition 322).
Ocean circulation plays a critical role in the Earth's climate system through the storage and transfer of heat and carbon dioxide. The North Atlantic and Southern Ocean are of particular interest because these are regions where deep-water components of global circulation develop. electricity deregulation choices and challenges Overall patterns and functioning of modern oceanic circulation is relatively well understood, but significant uncertainty remains about circulation in the geologic past and during different climate regimes. Dr. Romans uses the deep-sea sedimentary record to reconstruct past ocean circulation and its relationship to past climatic and tectonic conditions. He integrates information from a broad range of spatial and temporal scales, from seismic-reflection data that reveals regional sedimentation patterns to high-resolution records based on quantitative grain-size analysis from cores. Dr. shale gas in spanish Romans will present research from the North Atlantic Ocean (Expedition 342, Newfoundland Drifts) that shows how vast deep-sea "drift" deposits relate to the onset of and changes in ocean circulation in the Eocene through Miocene. In addition to his work on the North Atlantic, Dr. Romans will also present preliminary findings from new drilling (January-February 2018) in the Ross Sea (Expedition 374, West Antarctic Ice Sheet History), which aims to study interactions of Southern Ocean circulation and Antarctic ice sheet dynamics during significant climate events of the Miocene and Pliocene.
Dr. Romans is an associate professor in the Department of Geosciences at Virginia Tech. He received his Ph.D. in Geological & Environmental Sciences from Stanford University, M.S. in Geology & Geological Engineering, and undergraduate degree in Geology at SUNY Buffalo. Brian participated as a shipboard scientist on two IODP Expeditions (Expeditions 342 and 374).
The transfer of material and energy between Earth's ocean and lithosphere plays an important role in regulating climate and in the geochemical evolution of the ocean, crust, and mantle. The evolution of seawater composition is intimately linked to changes in the magnitude of element sources and sinks through geologic time. The modern chemical fluxes associated with river input and high-temperature hydrothermal circulation are well-constrained in comparison to the diffusive exchange between marine sediments and the ocean. Chemical reactions in marine sediments, however, play an important role in the marine biogeochemical cycles of many elements, as indicated by positive and negative gradients in their concentration in sediment pore water. These gradients are driven by seafloor and subseafloor diagenetic reactions such as microbial oxidation of organic carbon, methanogenesis and methane oxidation, authigenic carbonate and aluminosilicate mineral precipitation, ion exchange, and carbonate dissolution and recrystallization. Detailed studies of these reactions and associated chemical fluxes are often from only a few sites, making it difficult to extrapolate these fluxes globally. There has been a significant momentum over the past decade to constrain the global flux of elements and isotope ratios to/from marine sediments, motivated by the large pore water chemistry dataset acquired through scientific ocean drilling.
The large ocean drilling dataset collected over the past ~50 years covers a wide-variety of environments including abyssal ocean basins, convergent and divergent margins, back-arc basins, and a wide-range of areas with differing sedimentation rates, organic carbon burial, and sediment types. This characteristic diversity of the dataset lends itself well to reactive-transport modeling and modern machine-learning statistical techniques to constrain global element fluxes between the ocean and marine sediments. In this talk, I will present recent results from my research group and the broader marine geochemistry community using the ocean drilling dataset to evaluate diagenetic reactions occurring in continental margin sediments and the role of marine sediments in the oceanic cycles of a range of solutes and isotope ratios including Mg, d 26Mg, Ca, alkalinity, and Si. These new estimates provide a solid benchmark for the modern marine sediment source/sink and for exploring how the processes controlling seawater composition change throughout Earth's history.
Dr. Solomon is a marine geochemist/geologist who studies the transfer of water, solutes, isotope ratios, and carbon between the ocean and lithosphere. 5 gases Most recently, his research has focused on sediment diagenesis, subduction zone hydrogeology, cold seep dynamics, and the development and deployment of seafloor/subseafloor hydrologic observatories. Dr. Solomon has sailed on six ODP/IODP expeditions, including upcoming IODP Expedition 375 at the Hikurangi subuction zone, offshore New Zealand.


text:
Example of sunk cost in accounting - Meaning of "sunk costs" in the English dictionary Educalingo
los angeles or san francisco for example
Los Angeles Multi-day & Extended Tours: Check out Viator's reviews and photos of Los 2 days California Coast and Hearst Castle Tour from Los Angeles to San Francisco.
example of slope intercept form of a linear equation
Slope Intercept Scenarios. give examples of functions that are not linear. Tell them that they will be creating equations in slope intercept form,
best way to introduce yourself in an interview example
6/04/2012В В· How to Sell Yourself in Any Job Interview. Decide what your best trait is, and have a supporting example ready Introduce Yourself at a Job Interview.
example of highly processed foods
Examples of Processed Carbs. especially if you do so with refined or highly processed carbs, Any food containing added sugar has processed carbs.
example of enthalpy reaction equation
the equation for the standard enthalpy change of Example \(\PageIndex{3}\) The enthalpy of formation of carbon Simple Measurement of Enthalpy Changes of Reaction;
return on total assets calculation example
Here's how to calculate each one, as well as an example of each using 2015 data from Wells Fargo. Return on assets To calculate a bank by the total assets,
You can find us here:
Australian Capital Territory: Crookwell ACT, Fadden ACT, Canberra Airport ACT, Williamstown ACT, Hackett ACT, ACT Australia 2613
New South Wales: Mourquong NSW, Cope NSW, Kanwal NSW, Wattle Ponds NSW, Bardwell Park NSW, NSW Australia 2018
Northern Territory: Durack NT, Wagaman NT, Angurugu NT, Bayview NT, Dundee NT, Darwin River NT, NT Australia 0857
Queensland: Wujal Wujal QLD, Moonie QLD, Maroon QLD, Mt Coolum QLD, QLD Australia 4043
South Australia: St Morris SA, Coonalpyn SA, Birkenhead SA, Monarto South SA, Gerard SA, Littlehampton SA, SA Australia 5094
Tasmania: Nook TAS, Mt Direction TAS, Electrona TAS, TAS Australia 7055
Victoria: Toorloo Arm VIC, Glenorchy VIC, Allambee Reserve VIC, Yarrambat VIC, Granya VIC, VIC Australia 3004
Western Australia: Torbay WA, Harvey WA, Muntadgin WA, WA Australia 6046
British Columbia: Penticton BC, Smithers BC, Valemount BC, Comox BC, Coquitlam BC, BC Canada, V8W 5W4
Yukon: Takhini Hot Springs YT, Yukon Crossing YT, Mason Landing YT, Little River YT, Little River YT, YT Canada, Y1A 8C3
Alberta: St. Paul AB, Gibbons AB, Ponoka AB, Stony Plain AB, Magrath AB, Edberg AB, AB Canada, T5K 2J3
Northwest Territories: Nahanni Butte NT, Fort Resolution NT, Behchoko? NT, Fort Liard NT, NT Canada, X1A 4L5
Saskatchewan: Minton SK, Perdue SK, Wood Mountain SK, Annaheim SK, Paynton SK, Dinsmore SK, SK Canada, S4P 2C2
Manitoba: Binscarth MB, Rossburn MB, Ethelbert MB, MB Canada, R3B 2P9
Quebec: Tadoussac QC, Riviere-du-Loup QC, East Angus QC, Senneterre QC, Plessisville QC, QC Canada, H2Y 1W1
New Brunswick: Grand Falls NB, Rothesay NB, Petitcodiac NB, NB Canada, E3B 8H6
Nova Scotia: Kings NS, Parrsboro NS, Glace Bay NS, NS Canada, B3J 6S3
Prince Edward Island: Bayview PE, West River PE, St. Louis PE, PE Canada, C1A 3N7
Newfoundland and Labrador: Trinity NL, Rigolet NL, Carbonear NL, Long Harbour-Mount Arlington Heights NL, NL Canada, A1B 7J1
Ontario: Albion ON, Radiant ON, North Huron ON, Hilly Grove, Assiginack ON, Sand Bay Corner ON, Brant ON, ON Canada, M7A 3L5
Nunavut: Apex NU, Tavane (Tavani) NU, NU Canada, X0A 2H8
England: Telford ENG, Wakefield ENG, Kingswinford ENG, West Bromwich ENG, Southampton ENG, ENG United Kingdom W1U 9A6
Northern Ireland: Belfast NIR, Belfast NIR, Craigavon (incl. Lurgan, Portadown) NIR, Newtownabbey NIR, Craigavon (incl. Lurgan, Portadown) NIR, NIR United Kingdom BT2 8H3
Scotland: Edinburgh SCO, Cumbernauld SCO, Edinburgh SCO, Livingston SCO, Hamilton SCO, SCO United Kingdom EH10 8B7
Wales: Barry WAL, Newport WAL, Swansea WAL, Cardiff WAL, Newport WAL, WAL United Kingdom CF24 3D1


text:
Visual content – why it matters for 2019 (part 1)
In the first part of our Visual Content series we will focus on how images can improve your marketing strategy, and why you should take note of it going into 2019.
The statistics:
- Organic Facebook engagement is highest on posts with videos (13.9%) and photos (13.7%). Compared to less than 1% for non-visual based. (Source)
- Facebook posts with images see 2.3X more engagement than those without images. (Source)
- BuzzSumo found that articles (over 1 million analysed) with an image once every 75-100 words received double the social media shares as articles with fewer images. (Source)
- Tweets with images receive 150% more retweets than tweets without images. (Source)
- People following directions with text and illustrations do 323% better than people following directions without illustrations. (Source)
You can also save this handy infographic that sums up the above:
Why it matters?
In a world where organic reach across all social platforms is consistently dropping (Source) even reaching your own audience has become difficult. Being able to maximise your organic reach will save you thousands of rands instead of spending it on ads (or boosts) to reach the audience that you have already worked hard to get to. Being able to spend that money on reaching new audiences and growing your base is a much better strategy. By knowing how consumers react to different content that you put out there, you and your business can begin to take advantage of these numbers to ensure that your brand succeeds in both content and social marketing.
How to take advantage of it:
The simple answer is to include images in your posts, but it is not that easy. You need to think about the reaction that the image and the accompanying text will have.
What is the goal that you wish to achieve with the specific image and post? Is it for entertainment, or education? Are you looking for shares?
By planning ahead it becomes easier to plan specific posts that will improve your longer term goals and strategies. Remember SMARTER marketing from this post? Know what your goals are, and how each post will contribute to achieving that overall goal.